Speak directly to the analyst to clarify any post sales queries you may have.
The plant genomics market is shaping new strategies for agri-food and biotechnology sectors, compelling executives to address operational resilience, regulatory adaptation, and sustainable growth. Rapid innovation in genomics is transforming how organizations respond to emerging risks and maintain competitive advantage.
Market Snapshot: Plant Genomics Market Size, Growth, and Opportunities
The global plant genomics market is exhibiting robust growth, driven by escalating demand for advanced solutions that enhance food security and agriculture productivity. Market value is supported by the adoption of precision agriculture practices, integration of gene editing and sequencing across the value chain, and continued investment interest from key stakeholders. Both long-established multinationals and newer innovators are reshaping the market landscape, while evolving regulations are influencing procurement, operations, and supply chains. Organizations that prioritize agile adaptation and forward-looking strategies will benefit most in this changing environment.
Scope & Segmentation: Strategic Overview of the Plant Genomics Market
This report provides an actionable analysis for senior leaders, enabling competitive benchmarking and informed planning across multiple dimensions of the plant genomics market. The segmentation below highlights areas vital for investment and long-term strategy:
- Product Types: Genomic analysis instruments, reagents, consumables, specialized laboratory services, and advanced data management software drive consistency and precision in genomics workflows for organizations across the ecosystem.
- Technologies: Gene editing tools such as CRISPR and zinc finger nucleases support targeted genetic improvements; various polymerase chain reaction (PCR) methods deliver reliable DNA amplification; sequencing platforms range from Sanger to next-generation and third-generation technologies, expanding both depth and speed of research and development efforts.
- Service Models: Strategic consulting, contract research outsourcing, and data analysis offerings help streamline solution development, scale operational impact, and improve workflow efficiency for enterprises operating in genomics.
- Applications: Genomics innovation significantly impacts crop disease resistance, plant performance, genetic and infectious disease testing, prenatal evaluation, and biomarker discovery, broadening the use of plant genomics across diverse agri-food and biotech domains.
- End Users: Academic bodies continue advancing genomic research; agricultural enterprises employ these advancements to achieve higher productivity; hospitals and diagnostic labs address health testing needs; leading biotechnology and pharmaceutical organizations drive adoption and broader integration.
- Regions Covered: The Americas, Europe, Middle East and Africa, and Asia-Pacific—including prominent markets such as China, India, and Japan—are each prioritizing plant genomics strategies according to their regulatory frameworks and unique agricultural priorities.
- Companies Featured: Illumina, Thermo Fisher Scientific, BGI Genomics, QIAGEN, Agilent Technologies, PerkinElmer, Pacific Biosciences, Oxford Nanopore Technologies, Eurofins Scientific, and Merck KGaA are advancing innovation and leveraging their global reach in plant genomics.
Key Takeaways for Senior Decision-Makers
- High-throughput sequencing platforms are making crop improvement initiatives more responsive, helping ensure supply chain stability amid increased climate fluctuations.
- Artificial intelligence and machine learning are accelerating trait selection, allowing organizations to better meet dynamic market requirements.
- Expanded collaboration among technology providers, government entities, and private firms is unlocking scalable innovation and facilitating improved data sharing.
- Strengthening of partnerships and adoption of informatics tools are supporting long-term research resilience and streamlining core operations for leading agri-food and biotech companies.
- Entering new regions enables enterprises to adapt genomic technologies to specific local challenges, building capacity to address food security and sustainability across varied environments.
Tariff Impact: Navigating Regulatory and Supply Chain Disruptions
Upcoming United States tariffs are increasing the complexity of procuring reagents, instruments, and digital tools in the plant genomics sector. In response, procurement leaders are diversifying sourcing, encouraging domestic manufacturing, and working with regional suppliers to maintain supply chain continuity and support both agriculture and biotechnology operations.
Methodology & Data Sources
Research for this report draws upon interviews with sector leaders, procurement executives, and policymakers, along with analysis of peer-reviewed literature, current market trends, regulatory documents, and corporate reports. Data triangulation was used to ensure reliability and practical relevance for commercial application.
Why This Report Matters
- Empowers senior leaders with trend analysis and sector-specific data to inform investment, partnership, and product decisions in plant genomics.
- Enables proactive leadership by offering actionable intelligence and strategic guidance tailored to the diverse regulatory and operational challenges across regions.
- Directs organizations to adapt quickly to regulatory and supply chain changes, supporting reduced risk and more resilient operations.
Executives who leverage these insights will be equipped to anticipate shifts in the sector and maintain both operational continuity and competitive position as plant genomics continues to evolve.
Conclusion
Plant genomics is increasingly pivotal in agri-food and biotech strategies. The executive insights provided here support innovation, help catalyze sector growth, and enable organizations to build sustained competitive strength.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Plant Genomics market report include:- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics Co., Ltd.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies Limited
- Eurofins Scientific SE
- Merck KGaA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 12.23 Billion |
| Forecasted Market Value ( USD | $ 23.09 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


